Ann: CSO Precision Medicine Presentation, page-35

Hi syzygy. Im picking you've read recent announcements but just in case. On 10 April 2018 the Co/ announced the PTX 200 Phase 1b Breast Cancer results and refered to commencement of Phase 2 results. They dont give insite into how long the trial will take through. Historically there has been quite a big lead in in the cohort "selection" process. Phase 2 seems to envisage a two stage testing programme 11 then a further 15. The prerequisites of stage two gave already been met with the first 5 of 11 cohorts. So all pretty promising. Heres a relevant exerpt from the above refered announcement. just in case you haven't seen it.